Overview
The National Cancer Institute (NCI) will host the Co-Clinical Imaging Research Resource Program (CIRP) Annual Hybrid Meeting 2024. Join us on May 20 - 21, 2024 in-person at NCI Shady Grove Campus or virtually via WebEx to learn about how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers and applications of co-clinical imaging to oncology precision medicine.
The CIRP network was formed in 2018 based on a trans-NCI initiative, with joint effort of Cancer Imaging Program at Division of Cancer Treatment and Diagnosis, Division of Cancer Biology and Division of Cancer Prevention. The mission is to advance the practice of precision medicine by establishing consensus-based best practices for co-clinical imaging and developing optimized state-of-the-art translational quantitative imaging methodologies to enable disease detection, risk stratification, and assessment/prediction of response to therapy. Previous CIRP annual meetings can be found at https://wiki.nci.nih.gov/display/NCICRIP/Previous+Meetings.
When: Monday & Tuesday, May 20 - 21, 2024
Venue: In-person attending at NCI Shady Grove Campus. Virtual attending via WebEx Meeting, link will be available two weeks prior to the meeting date.
Call for posters:
This call for posters is open to all CIRP and non-CIRP affiliated investigators pursuing research within the scientific scope of the CIRP network. Investigators are invited to present posters on research progress achieved in their laboratory that are relevant to the scientific scope of CIRP network. Examples of topics include, but are not limited to:
- The use of Patient Derived Xenografts (PDXs) and Genetically Engineered Mouse Models (GEMMs) in therapeutic co-clinical trials.
- The use of quantitative imaging methods to assess and/or predict response in co-clinical therapeutic trials that employ GEMMS or PDXs in the preclinical arm.
- Advances in preclinical quantitative imaging, image acquisition, data processing and analysis, and methodological development.
- Informatics tools and methods for preclinical quantitative imaging of cancers.
- Integration of cancer -omics, pathology with preclinical and/or clinical quantitative imaging information.
- Resources to support co-clinical trials research.
Please send your one-page abstract to NCI program staff, Huiming Zhang, PhD (zhanghui@mail.nih.gov) by April 8, 2024. Submitted abstracts will be reviewed by the CIRP Steering Committee. Authors of accepted abstracts will be notified by email with instructions to prepare (1) Poster Power Pitch slides (2 slides for a 3-minute presentation) and (2) In-person attendees need to prepare a traditional poster (4X6 feet), and instructions to submit the slides by May 10, 2024.
Hotel for In-person Attendees:
If you plan to attend the meeting in-person and need a hotel room, please find the reservation link on the hotel page, and reserve your room before April 28, 2024.
Contact:
If there is a problem, please contact NCI Staff, Dr. Huiming Zhang, zhanghui@mail.nih.gov.
Important deadline:
Meeting registration is closed on May 6, 2024.
Abstracts for talks, demonstration and posters are due April 8, 2024.
Hotel Room Block Cut-off date is April 28, 2024.
Abstract format
The abstract is limited to one page word document, including title, authors, affiliations, text, figures, and references as necessary. List your contact information including email address and phone number. Use font of Time New Roman, single line space, text in size 12, title in size 14.